Financhill
Sell
1

SGRY Quote, Financials, Valuation and Earnings

Last price:
$20.01
Seasonality move :
-2.32%
Day range:
$19.79 - $20.40
52-week range:
$19.50 - $33.97
Dividend yield:
0%
P/E ratio:
--
P/S ratio:
0.81x
P/B ratio:
1.50x
Volume:
10.2M
Avg. volume:
1.4M
1-year change:
-19.1%
Market cap:
$2.6B
Revenue:
$3.1B
EPS (TTM):
-$1.53

Price Performance History

Performance vs. Valuation Benchmarks

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Competitors

Company Revenue Forecast Earnings Forecast Revenue Growth Forecast Earnings Growth Forecast Analyst Price Target Median
SGRY
Surgery Partners
$777.1M $0.05 7.29% 31.79% $31.36
DVA
DaVita
$3.2B $2.02 5.28% 10.44% $162.92
EHC
Encompass Health
$1.4B $1.19 9.58% 7.68% $131.58
LFST
LifeStance Health Group
$332.9M $0.01 11.21% -95.93% $8.86
SEM
Select Medical Holdings
$1.4B $0.45 -23.37% -60.55% $20.50
USPH
US Physical Therapy
$176.8M $0.45 13.42% 48.58% $106.00
Company Price Analyst Target Market Cap P/E Ratio Dividend per Share Dividend Yield Price / LTM Sales
SGRY
Surgery Partners
$20.33 $31.36 $2.6B -- $0.00 0% 0.81x
DVA
DaVita
$136.51 $162.92 $10.3B 13.53x $0.00 0% 0.89x
EHC
Encompass Health
$119.19 $131.58 $12B 24.63x $0.17 0.55% 2.21x
LFST
LifeStance Health Group
$5.04 $8.86 $2B -- $0.00 0% 1.50x
SEM
Select Medical Holdings
$14.73 $20.50 $1.9B 10.99x $0.06 1.76% 0.39x
USPH
US Physical Therapy
$77.34 $106.00 $1.2B 35.48x $0.45 2.3% 1.67x
Company Total Debt / Total Capital Beta Debt to Equity Quick Ratio
SGRY
Surgery Partners
67.11% 0.491 72.6% 1.40x
DVA
DaVita
102.82% 1.528 70.83% 1.12x
EHC
Encompass Health
53.38% 0.316 22.48% 0.84x
LFST
LifeStance Health Group
15.94% 1.095 10.67% 1.32x
SEM
Select Medical Holdings
51.37% 0.992 73.56% 1.02x
USPH
US Physical Therapy
25.08% 1.841 12.74% 1.05x
Company Gross Profit Operating Income Return on Invested Capital Return on Common Equity EBIT Margin Free Cash Flow
SGRY
Surgery Partners
$161.9M $89.6M -2.86% -5.45% 7.98% -$16.7M
DVA
DaVita
$983.9M $433.3M 7.42% 38.96% 13.07% $36.8M
EHC
Encompass Health
$630.9M $267M 9.36% 18.4% 18.58% $125.5M
LFST
LifeStance Health Group
$109.8M $1.6M -2.07% -2.48% 0.48% -$10.3M
SEM
Select Medical Holdings
$180.6M $112.7M 3.63% 8.92% 9.26% -$55.8M
USPH
US Physical Therapy
$31.1M $14.8M 3.81% 4.62% 10.67% -$7.3M

Surgery Partners vs. Competitors

  • Which has Higher Returns SGRY or DVA?

    DaVita has a net margin of -4.86% compared to Surgery Partners's net margin of 5.05%. Surgery Partners's return on equity of -5.45% beat DaVita's return on equity of 38.96%.

    Company Gross Margin Earnings Per Share Invested Capital
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
    DVA
    DaVita
    30.52% $2.00 $11.4B
  • What do Analysts Say About SGRY or DVA?

    Surgery Partners has a consensus price target of $31.36, signalling upside risk potential of 54.27%. On the other hand DaVita has an analysts' consensus of $162.92 which suggests that it could grow by 19.35%. Given that Surgery Partners has higher upside potential than DaVita, analysts believe Surgery Partners is more attractive than DaVita.

    Company Buy Ratings Hold Ratings Sell Ratings
    SGRY
    Surgery Partners
    8 3 0
    DVA
    DaVita
    1 8 0
  • Is SGRY or DVA More Risky?

    Surgery Partners has a beta of 1.931, which suggesting that the stock is 93.143% more volatile than S&P 500. In comparison DaVita has a beta of 1.107, suggesting its more volatile than the S&P 500 by 10.674%.

  • Which is a Better Dividend Stock SGRY or DVA?

    Surgery Partners has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. DaVita offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Surgery Partners pays -- of its earnings as a dividend. DaVita pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SGRY or DVA?

    Surgery Partners quarterly revenues are $776M, which are smaller than DaVita quarterly revenues of $3.2B. Surgery Partners's net income of -$37.7M is lower than DaVita's net income of $162.9M. Notably, Surgery Partners's price-to-earnings ratio is -- while DaVita's PE ratio is 13.53x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners is 0.81x versus 0.89x for DaVita. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SGRY
    Surgery Partners
    0.81x -- $776M -$37.7M
    DVA
    DaVita
    0.89x 13.53x $3.2B $162.9M
  • Which has Higher Returns SGRY or EHC?

    Encompass Health has a net margin of -4.86% compared to Surgery Partners's net margin of 10.41%. Surgery Partners's return on equity of -5.45% beat Encompass Health's return on equity of 18.4%.

    Company Gross Margin Earnings Per Share Invested Capital
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
    EHC
    Encompass Health
    43.35% $1.48 $5.4B
  • What do Analysts Say About SGRY or EHC?

    Surgery Partners has a consensus price target of $31.36, signalling upside risk potential of 54.27%. On the other hand Encompass Health has an analysts' consensus of $131.58 which suggests that it could grow by 10.4%. Given that Surgery Partners has higher upside potential than Encompass Health, analysts believe Surgery Partners is more attractive than Encompass Health.

    Company Buy Ratings Hold Ratings Sell Ratings
    SGRY
    Surgery Partners
    8 3 0
    EHC
    Encompass Health
    11 0 0
  • Is SGRY or EHC More Risky?

    Surgery Partners has a beta of 1.931, which suggesting that the stock is 93.143% more volatile than S&P 500. In comparison Encompass Health has a beta of 0.903, suggesting its less volatile than the S&P 500 by 9.671%.

  • Which is a Better Dividend Stock SGRY or EHC?

    Surgery Partners has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Encompass Health offers a yield of 0.55% to investors and pays a quarterly dividend of $0.17 per share. Surgery Partners pays -- of its earnings as a dividend. Encompass Health pays out 13.78% of its earnings as a dividend. Encompass Health's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios SGRY or EHC?

    Surgery Partners quarterly revenues are $776M, which are smaller than Encompass Health quarterly revenues of $1.5B. Surgery Partners's net income of -$37.7M is lower than Encompass Health's net income of $151.5M. Notably, Surgery Partners's price-to-earnings ratio is -- while Encompass Health's PE ratio is 24.63x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners is 0.81x versus 2.21x for Encompass Health. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SGRY
    Surgery Partners
    0.81x -- $776M -$37.7M
    EHC
    Encompass Health
    2.21x 24.63x $1.5B $151.5M
  • Which has Higher Returns SGRY or LFST?

    LifeStance Health Group has a net margin of -4.86% compared to Surgery Partners's net margin of 0.21%. Surgery Partners's return on equity of -5.45% beat LifeStance Health Group's return on equity of -2.48%.

    Company Gross Margin Earnings Per Share Invested Capital
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
    LFST
    LifeStance Health Group
    32.97% -- $1.7B
  • What do Analysts Say About SGRY or LFST?

    Surgery Partners has a consensus price target of $31.36, signalling upside risk potential of 54.27%. On the other hand LifeStance Health Group has an analysts' consensus of $8.86 which suggests that it could grow by 75.74%. Given that LifeStance Health Group has higher upside potential than Surgery Partners, analysts believe LifeStance Health Group is more attractive than Surgery Partners.

    Company Buy Ratings Hold Ratings Sell Ratings
    SGRY
    Surgery Partners
    8 3 0
    LFST
    LifeStance Health Group
    5 1 0
  • Is SGRY or LFST More Risky?

    Surgery Partners has a beta of 1.931, which suggesting that the stock is 93.143% more volatile than S&P 500. In comparison LifeStance Health Group has a beta of 0.000, suggesting its less volatile than the S&P 500 by 100%.

  • Which is a Better Dividend Stock SGRY or LFST?

    Surgery Partners has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. LifeStance Health Group offers a yield of 0% to investors and pays a quarterly dividend of $0.00 per share. Surgery Partners pays -- of its earnings as a dividend. LifeStance Health Group pays out -- of its earnings as a dividend.

  • Which has Better Financial Ratios SGRY or LFST?

    Surgery Partners quarterly revenues are $776M, which are larger than LifeStance Health Group quarterly revenues of $333M. Surgery Partners's net income of -$37.7M is lower than LifeStance Health Group's net income of $709K. Notably, Surgery Partners's price-to-earnings ratio is -- while LifeStance Health Group's PE ratio is --. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners is 0.81x versus 1.50x for LifeStance Health Group. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SGRY
    Surgery Partners
    0.81x -- $776M -$37.7M
    LFST
    LifeStance Health Group
    1.50x -- $333M $709K
  • Which has Higher Returns SGRY or SEM?

    Select Medical Holdings has a net margin of -4.86% compared to Surgery Partners's net margin of 4.19%. Surgery Partners's return on equity of -5.45% beat Select Medical Holdings's return on equity of 8.92%.

    Company Gross Margin Earnings Per Share Invested Capital
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
    SEM
    Select Medical Holdings
    13.34% $0.44 $3.9B
  • What do Analysts Say About SGRY or SEM?

    Surgery Partners has a consensus price target of $31.36, signalling upside risk potential of 54.27%. On the other hand Select Medical Holdings has an analysts' consensus of $20.50 which suggests that it could grow by 39.17%. Given that Surgery Partners has higher upside potential than Select Medical Holdings, analysts believe Surgery Partners is more attractive than Select Medical Holdings.

    Company Buy Ratings Hold Ratings Sell Ratings
    SGRY
    Surgery Partners
    8 3 0
    SEM
    Select Medical Holdings
    4 1 0
  • Is SGRY or SEM More Risky?

    Surgery Partners has a beta of 1.931, which suggesting that the stock is 93.143% more volatile than S&P 500. In comparison Select Medical Holdings has a beta of 1.341, suggesting its more volatile than the S&P 500 by 34.132%.

  • Which is a Better Dividend Stock SGRY or SEM?

    Surgery Partners has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. Select Medical Holdings offers a yield of 1.76% to investors and pays a quarterly dividend of $0.06 per share. Surgery Partners pays -- of its earnings as a dividend. Select Medical Holdings pays out 30.19% of its earnings as a dividend. Select Medical Holdings's payout ratio is sufficient to cover dividend payouts with earnings for the foreseeable future.

  • Which has Better Financial Ratios SGRY or SEM?

    Surgery Partners quarterly revenues are $776M, which are smaller than Select Medical Holdings quarterly revenues of $1.4B. Surgery Partners's net income of -$37.7M is lower than Select Medical Holdings's net income of $56.7M. Notably, Surgery Partners's price-to-earnings ratio is -- while Select Medical Holdings's PE ratio is 10.99x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners is 0.81x versus 0.39x for Select Medical Holdings. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SGRY
    Surgery Partners
    0.81x -- $776M -$37.7M
    SEM
    Select Medical Holdings
    0.39x 10.99x $1.4B $56.7M
  • Which has Higher Returns SGRY or USPH?

    US Physical Therapy has a net margin of -4.86% compared to Surgery Partners's net margin of 6.97%. Surgery Partners's return on equity of -5.45% beat US Physical Therapy's return on equity of 4.62%.

    Company Gross Margin Earnings Per Share Invested Capital
    SGRY
    Surgery Partners
    20.86% -$0.30 $7.1B
    USPH
    US Physical Therapy
    16.9% $0.80 $925.5M
  • What do Analysts Say About SGRY or USPH?

    Surgery Partners has a consensus price target of $31.36, signalling upside risk potential of 54.27%. On the other hand US Physical Therapy has an analysts' consensus of $106.00 which suggests that it could grow by 37.06%. Given that Surgery Partners has higher upside potential than US Physical Therapy, analysts believe Surgery Partners is more attractive than US Physical Therapy.

    Company Buy Ratings Hold Ratings Sell Ratings
    SGRY
    Surgery Partners
    8 3 0
    USPH
    US Physical Therapy
    2 1 0
  • Is SGRY or USPH More Risky?

    Surgery Partners has a beta of 1.931, which suggesting that the stock is 93.143% more volatile than S&P 500. In comparison US Physical Therapy has a beta of 1.451, suggesting its more volatile than the S&P 500 by 45.087%.

  • Which is a Better Dividend Stock SGRY or USPH?

    Surgery Partners has a quarterly dividend of $0.00 per share corresponding to a yield of 0%. US Physical Therapy offers a yield of 2.3% to investors and pays a quarterly dividend of $0.45 per share. Surgery Partners pays -- of its earnings as a dividend. US Physical Therapy pays out 100.3% of its earnings as a dividend.

  • Which has Better Financial Ratios SGRY or USPH?

    Surgery Partners quarterly revenues are $776M, which are larger than US Physical Therapy quarterly revenues of $183.8M. Surgery Partners's net income of -$37.7M is lower than US Physical Therapy's net income of $12.8M. Notably, Surgery Partners's price-to-earnings ratio is -- while US Physical Therapy's PE ratio is 35.48x. Generally a lower price-to-earnings ratio signals a stock is trading at a lower multiple of earnings and is a better value. Another key metric is the price-to-sales ratio, which for Surgery Partners is 0.81x versus 1.67x for US Physical Therapy. Usually stocks with elevated PS ratios are considered overvalued.

    Company Price/Sales Ratio Price/Earnings Ratio Quarterly Revenue Quarterly Net Income
    SGRY
    Surgery Partners
    0.81x -- $776M -$37.7M
    USPH
    US Physical Therapy
    1.67x 35.48x $183.8M $12.8M

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

AMC Stock Forecast, How High Could It Go in 2025 and Beyond?
AMC Stock Forecast, How High Could It Go in 2025 and Beyond?

AMC Entertainment (NYSE:AMC) has been rising lately after years of…

Where Will Reddit Stock Be In 5 Years?
Where Will Reddit Stock Be In 5 Years?

On a wet March morning last year, the famously orange…

Will Palantir Crash?
Will Palantir Crash?

AI and data analytics software major Palantir (NASDAQ:PLTR) has been…

Stock Ideas

Buy
65
Is MSFT Stock a Buy?

Market Cap: $3.6T
P/E Ratio: 41x

Buy
59
Is NVDA Stock a Buy?

Market Cap: $3.5T
P/E Ratio: 49x

Sell
39
Is AAPL Stock a Buy?

Market Cap: $2.9T
P/E Ratio: 32x

Alerts

Sell
47
RGC alert for Jun 18

Regencell Bioscience Holdings [RGC] is down 22.05% over the past day.

Sell
20
ENPH alert for Jun 18

Enphase Energy [ENPH] is up 3.49% over the past day.

Sell
26
FSLR alert for Jun 18

First Solar [FSLR] is down 0.14% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock